Phathom Pharmaceuticals, Inc. (PHAT) Dividend History

Phathom Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing treatments for gastrointestinal diseases. The company aims to address unmet medical needs through innovative therapies, with a particular emphasis on conditions such as acid-related disorders.

100 Campus Drive,, Florham Park, NJ, 07932
Phone: (877) 742-8466
Website: https://www.phathompharma.com

Dividend History

Phathom Pharmaceuticals, Inc. currently does not pay dividends

Company News

Phathom Pharmaceuticals Clarifies That There Is No Reduction in Lead Shareholder’s Ownership Following Administrative Change to 13D Filing

Phathom Pharmaceuticals announced administrative changes to a Schedule 13D filing by Frazier Life Sciences, emphasizing that these changes do not represent a reduction in ownership position, but rather reflect reporting approach modifications.

GlobeNewswire Inc.
The Top 3 Most-Shorted Stocks in August

The article discusses the top 3 most-shorted stocks in August, including Beyond Meat (BYND), Phathom Pharmaceuticals (PHAT), and Groupon (GRPN). It analyzes the short interest, financial performance, and market outlook for each company.

Investing.com

Featured Companies: BYND GRPN
Wall Street Breakfast: The Week Ahead

Stay up to date with the latest financial news! Listen to the Wall Street Breakfast podcast on Seeking Alpha, iTunes, and Spotify.

Seeking Alpha

Featured Companies: AVAV AYI BKR BNED CCL DDOG DHAI DLO FDX GIS INSM LEVI MKC MU NKE PAYX SRG WBA XAIR ZNTL
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Lags Revenue Estimates

Phathom Pharmaceuticals (PHAT) delivered earnings and revenue surprises of 0.70% and 30.73%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research

Featured Companies: AKYA
Walmart Posts Upbeat Earnings, Joins Armstrong World Industries, Owens & Minor And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were mostly lower, with the Nasdaq Composite falling more than 200 points on Tuesday. Shares of Walmart Inc. (NYSE: WMT) rose in today’s session after the company reported better-than-expected fourth-quarter financial results. Walmart reported fourth-quarter FY24 net sales growth of 5.7% year-over-year to $173.39 billion, beating the consensus of $170.71 billion. Adjusted EPS was $1.80, beating the consensus of $1.65. The board approved an annual cash dividend for fiscal year 2025 of 83 cents per share on a post-stock split basis or $2.49 per share on a pre-split basis, approximately a 9% increase from the $2.28 per share paid for the last fiscal year. Walmart shares gained 4.9% to $178.66 on Tuesday. Here are some other big stocks recording gains in today’s session. Iovance Biotherapeutics, ...

Benzinga

Featured Companies: AWI COF IOVA OMI TDS WMT

Page data last updated 09/06/2025 12:14:17 UTC